Delayed Onset Post-ERCP Pancreatitis (DOPE-P)

Journal Title: Pancreas – Open Journal - Year 2018, Vol 2, Issue 1

Abstract

Post Endoscopic retrograde cholangiopancreatography (ERCP) Pancreatitis (PEP) is defined as new onset or worsening of pain abdomen after ERCP with an elevation of pancreatic enzymes (amylase/lipase) more than 3 times upper limit of normal after 24 hours of procedure and prolongation of hospital stay/planned admission.1,2,3 The overall incidence of PEP is estimated to be 3-10%.1,2,3 Various risk factors found in multivariate trials are divided into patient-related risk factor (prior PEP, female sex, young patient, normal bilirubin, previous recurrent pancreatitis, suspected sphincter of Oddi dysfunction, absence of chronic pancreatitis) and procedure-related risk factors (difficult cannulation i.e. >10 minutes cannulation time, repetitive pancreatic duct guide wire cannulation, pancreatic duct contrast injection, pancreatic sphincterotomy, endoscopic papillary large-balloon dilatation of an intact sphincter). Placement of prophylactic pancreatic stents (PPSs) usually advocated in high-risk patients and reduced PEP rate by 60-80%.4,5 3 Fr stents have higher migration rate and hence 5 Fr stents are superior to 3 Fr. Studies have shown that if placement of pancreatic stent is attempted but fails risk of PEP increases.

Authors and Affiliations

Vishal Khurana

Keywords

Related Articles

Nutritional Support of Patients With the Abdominal Compartment Syndrome During Severe Acute Pancreatitis

There is growing evidence in the literature that development of Abdominal Compartment Syndrome (ACS) in patients with Severe Acute Pancreatitis (SAP) has a strong impact on the course of disease. Incidence of ACS in pati...

Effects of Obesity and Diabetes on Beta-Cell Mass in Japanese

The prevalence of type 2 diabetes mellitus (T2DM) continues to increase all over the world. T2DM is characterized by insulin resistance and β-cell dysfunction. Recent studies have shown that β-cell dysfunction, but not i...

Eus-Pancreaticogastrostomy in a Patient with Subtotal Gastrectomy and Roux-En-Y Reconstruction

Chronic Pancreatitis (CP) is often associated with pain due to pancreatic duct obstruction. In these patients, surgical drainage was more effective than endoscopic treatment, achieving a faster, effective, and sustained...

Epigenetic Alterations in Pancreatic Cancer

Pancreatic cancer is the fourth leading cause of cancer death and is predicted to be the second leading cause in a decade in the US. Despite more than 50 years of research and therapeutic development, pancreatic cancer s...

Pancreas: Do All Roads Lead to Mitochondria?

Over several millions of years of evolution, mitochondria have transformed into specialized organelles. Today, they cannot live outside the cell nor can the host cell live without them, resulting in a symbiotic relations...

Download PDF file
  • EP ID EP556746
  • DOI 10.17140/POJ-2-e008
  • Views 140
  • Downloads 0

How To Cite

Vishal Khurana (2018). Delayed Onset Post-ERCP Pancreatitis (DOPE-P). Pancreas – Open Journal, 2(1), 8-9. https://europub.co.uk/articles/-A-556746